相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is stiripentol truly effective for treating primary hyperoxaluria?
Cristina Martin-Higueras et al.
CLINICAL KIDNEY JOURNAL (2021)
Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study
Bernd Hoppe et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Sander F. Garrelfs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Transplantation outcomes in patients with primary hyperoxaluria: a systematic review
Elisabeth L. Metry et al.
PEDIATRIC NEPHROLOGY (2021)
Stiripentol for the treatment of primary hyperoxaluria and calcium oxalate nephropathy
Christina M. Wyatt et al.
KIDNEY INTERNATIONAL (2020)
Inherited conditions resulting in nephrolithiasis
Bernd Hoppe et al.
CURRENT OPINION IN PEDIATRICS (2020)
The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce
Louise McAlister et al.
PEDIATRIC NEPHROLOGY (2020)
End Points for Clinical Trials in Primary Hyperoxaluria
Dawn S. Milliner et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning
Marine Le Dudal et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Recent advances in the identification and management of inherited hyperoxalurias
David J. Sas et al.
UROLITHIASIS (2019)
Oxalate Quantification in Hemodialysate to Assess Dialysis Adequacy for Primary Hyperoxaluria
Xiaojing Tang et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type
Giorgia Mandrile et al.
KIDNEY INTERNATIONAL (2014)
Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1
Sonia Fargue et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Primary Hyperoxaluria
Pierre Cochat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Characteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy
Jerome Harambat et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
Pierre Cochat et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria
Bernd Hoppe et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Immediate Postoperative Intensive Care Treatment of Pediatric Combined Liver-Kidney Transplantation: Outcome and Prognostic Factors
Egmont Harps et al.
TRANSPLANTATION (2011)
Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome
Jerome Harambat et al.
KIDNEY INTERNATIONAL (2010)
Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1
F. Illies et al.
KIDNEY INTERNATIONAL (2006)
Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria
Y Ogawa et al.
UROLOGICAL RESEARCH (2006)
A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): The European PH1 Transplant Registry experience 1984-2004
NV Jamieson
AMERICAN JOURNAL OF NEPHROLOGY (2005)
Primary hyperoxaluria - The German experience
B Hoppe et al.
AMERICAN JOURNAL OF NEPHROLOGY (2005)
Clinical implications of mutation analysis in primary hyperoxaluria type 1
CS van Woerden et al.
KIDNEY INTERNATIONAL (2004)
One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: A single-center experience
MT Millan et al.
TRANSPLANTATION (2003)
Phenotypic expression of primary hyperoxaluria: Comparative features of types I and II
DS Milliner et al.
KIDNEY INTERNATIONAL (2001)
分享论文
